Home › Funds › ADAR1 Capital Management, LLC › FULC
ADAR1 Capital Management, LLC position in FULC
FULCRUM THERAPEUTICS INC · Health Care
ADAR1 Capital Management, LLC reported holding 6,648,027 shares of FULC (FULCRUM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$24.6M, representing 1.35% of its reported portfolio and ranking #13 among its reported holdings. ADAR1 Capital Management, LLC has disclosed FULC holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How ADAR1 Capital Management, LLC's FULC position evolved
ADAR1 Capital Management, LLC first disclosed a stake in FULC in Q4 2023 at 637,405 shares (US$4.3M). The position peaked in Q3 2026 at 6,648,027 shares, worth US$24.6M. Across 12 filings, ADAR1 Capital Management, LLC increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 6,648,027 shares valued at US$24.6M — an increase of 5,082,998 shares quarter over quarter.. Notable position changes include a 1208% increase in Q4 2024 (shares fell 39% over the following quarter), a 1099% increase in Q2 2026 (shares rose 1% over the following quarter), a 325% increase in Q3 2026 (shares rose 2% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 637.40K | $4.30M | New |
| Q1 2024 | 339.82K | $3.21M | Reduce |
| Q2 2024 | 20.00K | $124.00K | Reduce |
| Q3 2024 | 15.00K | $53.55K | Reduce |
| Q4 2024 | 196.25K | $922.37K | Add |
| Q1 2025 | 490.53K | $1.41M | Add |
| Q2 2025 | 53.35K | $367.04K | Reduce |
| Q3 2025 | 75.00K | $690.00K | Add |
| Q4 2025 | 65.00K | $735.15K | Reduce |
| Q1 2026 | 130.56K | $1.00M | Add |
| Q2 2026 | 1.57M | $5.73M | Add |
| Q3 2026 | 6.65M | $24.60M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About FULC and 13F data
FULC (FULCRUM THERAPEUTICS INC) is a Health Care company. 26 other funds we track also report a position in FULC — the largest reported positions include EcoR1 Capital, LLC (US$25.2M), Nantahala Capital Management, LLC (US$24.3M), TANG CAPITAL MANAGEMENT LLC (US$23.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding FULC
- EcoR1 Capital, LLC 6.80M sh · $25.17M · Q3 2026
- Nantahala Capital Management, LLC 6.58M sh · $24.33M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 6.52M sh · $23.87M · Q2 2026
- GSK plc 1.79M sh · $6.61M · Q3 2026
More on ADAR1 Capital Management, LLC
FAQ
How long has ADAR1 Capital Management, LLC held FULC?
ADAR1 Capital Management, LLC has disclosed FULC holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is ADAR1 Capital Management, LLC's current position in FULC?
As of Q3 2026, ADAR1 Capital Management, LLC holds 6.65M shares of FULC (FULCRUM THERAPEUTICS INC), valued at $24.60M, representing 1.35% of its reported portfolio and ranking #13.
Has ADAR1 Capital Management, LLC been buying or selling FULC?
In the latest 13F filing (Q3 2026), ADAR1 Capital Management, LLC increased its position in FULC. The position peaked in Q3 2026 at 6.65M shares.
Which other funds hold FULC?
Other major institutional holders of FULC include EcoR1 Capital, LLC, Nantahala Capital Management, LLC, TANG CAPITAL MANAGEMENT LLC, among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.